MedDataX Logo

Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain

NCT ID: NCT01659372

Last Updated: 2012-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of cases pain is the major complaint.we run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

TMD

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

temporomandibular disorder myofascial pain syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low level laser therapy

this arm recieves low level laser therapy treatment for 12 sessions.

Group Type EXPERIMENTAL

low level laser therapy

Intervention Type RADIATION

naproxen

this arm takes naproxen 500 mg twice daily for 3weeks

Group Type EXPERIMENTAL

Naproxen

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low level laser therapy

Intervention Type RADIATION

Naproxen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with TMD affecting masticatory muscles

Exclusion Criteria

* systemic disease
* GI problem
* pregnancy
* epidermal cancer
Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shahid Beheshti University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

saranaz azari-marhabi

oral medicine resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shahid Beheshti University

Tehran, , Iran

Site Status NOT_YET_RECRUITING

Shahid Beheshti University

Tehran, , Iran

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

saranaz azari marhabi, post graduate student

Role: CONTACT

Phone: 00989190129151

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

saranaz azari-marhabi, doctor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ABT-1233-RV

Identifier Type: -

Identifier Source: org_study_id